Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Block vs Prochlorperazine for Pediatric Migraine
NCT03984045Phase 3Unknown
- Sponsor
- Newark Beth Israel Medical Center
- Start
- Jun 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in migraine, sponsored by Newark Beth Israel Medical Center. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03984045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03984045.